{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T23:24:06Z","timestamp":1648769046079},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00101-005-0957-4","type":"journal-article","created":{"date-parts":[[2005,12,21]],"date-time":"2005-12-21T08:36:53Z","timestamp":1135154213000},"page":"95-109","source":"Crossref","is-referenced-by-count":2,"title":["Hepatorenales Syndrom"],"prefix":"10.1007","volume":"55","author":[{"given":"I.","family":"K\u00fcrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sommerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Puhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Kaisers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Boemke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"957_CR1","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"Akriviadis","year":"2000","unstructured":"Akriviadis E, Botla R, Briggs W et al. (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119(6):1637\u20131648","journal-title":"Gastroenterology"},{"key":"957_CR2","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","volume":"41","author":"Alessandria","year":"2005","unstructured":"Alessandria C, Ozdogan O, Guevara M et al. (2005) MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 41(6):1282\u20131289","journal-title":"Hepatology"},{"key":"957_CR3","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","volume":"29","author":"Angeli","year":"1999","unstructured":"Angeli P, Volpin R, Gerunda G et al. (1999) Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29(6):1690\u20131697","journal-title":"Hepatology"},{"key":"957_CR4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"Arroyo","year":"1996","unstructured":"Arroyo V, Gines P, Gerbes AL et al. (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23(1):164\u2013176","journal-title":"Hepatology"},{"key":"957_CR5","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1053\/gast.2002.33575","volume":"122","author":"Arroyo","year":"2002","unstructured":"Arroyo V, Guevara M, Gines P (2002) Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology 122(6):1658\u20131676","journal-title":"Gastroenterology"},{"key":"957_CR6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.1840140313","volume":"14","author":"Bacq","year":"1991","unstructured":"Bacq Y, Gaudin C, Hadengue A et al. (1991) Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology 14(3):483\u2013487","journal-title":"Hepatology"},{"key":"957_CR7","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(00)03495-4","volume":"356","author":"Bellomo","year":"2000","unstructured":"Bellomo R, Chapman M, Finfer S et al. (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356(9248):2139\u20132143","journal-title":"Lancet"},{"key":"957_CR8","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1681\/ASN.V981489","volume":"9","author":"Carstens","year":"1998","unstructured":"Carstens J, Greisen J, Jensen KT et al. (1998) Renal effects of a urodilatin infusion in patients with liver cirrhosis, with and without ascites. J Am Soc Nephrol 9(8):1489\u20131498","journal-title":"J Am Soc Nephrol"},{"key":"957_CR9","first-page":"245","volume":"41","author":"Davenport","year":"1993","unstructured":"Davenport A, Will EJ, Davison AM (1993) Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl 41:245\u2013251","journal-title":"Kidney Int Suppl"},{"key":"957_CR10","first-page":"120","volume":"10","author":"Epstein","year":"1997","unstructured":"Epstein M, Goligorsky MS (1997) Endothelin and nitric oxide in hepatorenal syndrome: a balance reset. J Nephrol 10(3):120\u2013135","journal-title":"J Nephrol"},{"key":"957_CR11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/jhep.2003.50119","volume":"37","author":"Evans","year":"2003","unstructured":"Evans LT, Kim WR, Poterucha JJ, Kamath PS (2003) Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 37(4):897\u2013901","journal-title":"Hepatology"},{"key":"957_CR12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0168-8278(95)80003-4","volume":"23","author":"Forrest","year":"1995","unstructured":"Forrest EH, Jones AL, Dillon JF et al. (1995) The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis. J Hepatol 23(3):254\u2013258","journal-title":"J Hepatol"},{"key":"957_CR13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0016-5085(93)90431-B","volume":"104","author":"Gentilini","year":"1993","unstructured":"Gentilini P, Romanelli RG, La Villa G et al. (1993) Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gastroenterology 104(2):588\u2013594","journal-title":"Gastroenterology"},{"key":"957_CR14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hep.510280313","volume":"28","author":"Gerbes","year":"1998","unstructured":"Gerbes AL, Gulberg V, Waggershauser T et al. (1998) Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites. Hepatology 28(3):683\u2013688","journal-title":"Hepatology"},{"key":"957_CR15","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","volume":"123","author":"Gines","year":"2002","unstructured":"Gines P, Uriz J, Calahorra B et al. (2002) Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 123(6):1839\u20131847","journal-title":"Gastroenterology"},{"key":"957_CR16","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"Gines","year":"2003","unstructured":"Gines P, Guevara M, Arroyo V, Rodes J (2003) Hepatorenal syndrome. Lancet 362(9398):1819\u20131827","journal-title":"Lancet"},{"key":"957_CR17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hep.20313","volume":"40","author":"Gines","year":"2004","unstructured":"Gines P, Guevara M, Perez-Villa F (2004) Management of hepatorenal syndrome: another piece of the puzzle. Hepatology 40(1):16\u201318","journal-title":"Hepatology"},{"key":"957_CR18","unstructured":"Gonwa TA, Wilkinson AH (1996) Liver transplanation and renal function: results in patients with and without hepatorenal syndrome. In: Epstein (ed) The kidney in liver disease, 4th edn. Hanley & Belfus, Philadelphia, pp 529\u2013542"},{"key":"957_CR19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biocel.2004.06.007","volume":"37","author":"Guevara","year":"2005","unstructured":"Guevara M, Rodes J (2005) Hepatorenal syndrome. Int J Biochem Cell Biol 37(1):22\u201326","journal-title":"Int J Biochem Cell Biol"},{"key":"957_CR20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.510300430","volume":"30","author":"Gulberg","year":"1999","unstructured":"Gulberg V, Bilzer M, Gerbes AL (1999) Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology 30(4):870\u2013875","journal-title":"Hepatology"},{"key":"957_CR21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","volume":"29","author":"Hadengue","year":"1998","unstructured":"Hadengue A, Gadano A, Moreau R et al. (1998) Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 29(4):565\u2013570","journal-title":"J Hepatol"},{"key":"957_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-1007296","volume":"14","author":"Henriksen","year":"1994","unstructured":"Henriksen JH, Ring-Larsen H (1994) Hepatorenal disorders: role of the sympathetic nervous system. Semin Liver Dis 14(1):35\u201343","journal-title":"Semin Liver Dis"},{"key":"957_CR23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(05)74933-3","volume":"353","author":"Holt","year":"1999","unstructured":"Holt S, Goodier D, Marley R et al. (1999) Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet 353(9149):294\u2013295","journal-title":"Lancet"},{"key":"957_CR24","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1097\/00007890-199712270-00024","volume":"64","author":"Jeyarajah","year":"1997","unstructured":"Jeyarajah DR, Gonwa TA, McBride M et al. (1997) Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation 64(12):1760\u20131765","journal-title":"Transplantation"},{"key":"957_CR25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM196906192802501","volume":"280","author":"Koppel","year":"1969","unstructured":"Koppel MH, Coburn JW, Mims MM et al. (1969) Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. N Engl J Med 280(25):1367\u20131371","journal-title":"N Engl J Med"},{"key":"957_CR26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000084727","volume":"23","author":"Klupp","year":"2005","unstructured":"Klupp J, Kohler S, Pascher A, Neuhaus P (2005) Liver transplantation as ultimate tool to treat portal hypertension. Dig Dis 23(1):65\u201371","journal-title":"Dig Dis"},{"key":"957_CR27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","volume":"339","author":"Martin","year":"1998","unstructured":"Martin PY, Gines P, Schrier RW (1998) Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 339(8):533\u2013541","journal-title":"N Engl J Med"},{"key":"957_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","volume":"6","author":"Mitzner","year":"2000","unstructured":"Mitzner SR, Stange J, Klammt S et al. (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6(3):277\u2013286","journal-title":"Liver Transpl"},{"key":"957_CR29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/0016-5085(91)90284-R","volume":"100","author":"Moore","year":"1991","unstructured":"Moore K, Ward PS, Taylor GW, Williams R (1991) Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology 100(4):1069\u20131077","journal-title":"Gastroenterology"},{"key":"957_CR30","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJM199212173272502","volume":"327","author":"Moore","year":"1992","unstructured":"Moore K, Wendon J, Frazer M et al. (1992) Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327(25):1774\u20131778","journal-title":"N Engl J Med"},{"key":"957_CR31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","volume":"122","author":"Moreau","year":"2002","unstructured":"Moreau R, Durand F, Poynard T et al. (2002) Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 122(4):923\u2013930","journal-title":"Gastroenterology"},{"key":"957_CR32","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199505043321803","volume":"332","author":"Ochs","year":"1995","unstructured":"Ochs A, Rossle M, Haag K et al. (1995) The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 332(18):1192\u20131197","journal-title":"N Engl J Med"},{"key":"957_CR33","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"Ortega","year":"2002","unstructured":"Ortega R, Gines P, Uriz J et al. (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36(4 Pt 1):941\u2013948","journal-title":"Hepatology"},{"key":"957_CR34","first-page":"F364","volume":"258","author":"Persson","year":"1990","unstructured":"Persson PB, Ehmke H, Nafz B, Kirchheim HR (1990) Sympathetic modulation of renal autoregulation by carotid occlusion in conscious dogs. Am J Physiol 258(2 Pt 2):F364\u2013370","journal-title":"Am J Physiol"},{"key":"957_CR35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","volume":"40","author":"Restuccia","year":"2004","unstructured":"Restuccia T, Ortega R, Guevara M et al. (2004) Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol 40(1):140\u2013146","journal-title":"J Hepatol"},{"key":"957_CR36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","volume":"32","author":"Rimola","year":"2000","unstructured":"Rimola A, Garcia-Tsao G, Navasa M et al. (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32(1):142\u2013153","journal-title":"J Hepatol"},{"key":"957_CR37","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","volume":"342","author":"Rossle","year":"2000","unstructured":"Rossle M, Ochs A, Gulberg V et al. (2000) A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 342(23):1701\u20131707","journal-title":"N Engl J Med"},{"key":"957_CR38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.510270139","volume":"27","author":"Runyon","year":"1998","unstructured":"Runyon BA (1998) Management of adult patients with ascites caused by cirrhosis. Hepatology 27(1):264\u2013272","journal-title":"Hepatology"},{"key":"957_CR39","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s001080170018","volume":"42","author":"Saner","year":"2001","unstructured":"Saner F, Hertl M, Broelsch CE (2001) Das hepatorenale Syndrom. Internist 42(12):1666\u20131671","journal-title":"Internist"},{"key":"957_CR40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1525-1594.2002.06931_1.x","volume":"26","author":"Sauer","year":"2002","unstructured":"Sauer IM, Gerlach JC (2002) Modular extracorporeal liver support. Artif Organs 26(8):703\u2013706","journal-title":"Artif Organs"},{"key":"957_CR41","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/hep.20195","volume":"39","author":"Sauer","year":"2004","unstructured":"Sauer IM, Goetz M, Steffen I et al. (2004) In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 39(5):1408\u20131414","journal-title":"Hepatology"},{"key":"957_CR42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V et al. (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341(6):403\u2013409","journal-title":"N Engl J Med"},{"key":"957_CR43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","volume":"343","author":"Tepel","year":"2000","unstructured":"Tepel M, van der Giet M, Schwarzfeld C et al. (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343(3):180\u2013184","journal-title":"N Engl J Med"},{"key":"957_CR44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","volume":"33","author":"Uriz","year":"2000","unstructured":"Uriz J, Gines P, Cardenas A et al. (2000) Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 33(1):43\u201348","journal-title":"J Hepatol"},{"key":"957_CR45","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/gut.21.6.545","volume":"21","author":"Wilkinson","year":"1980","unstructured":"Wilkinson SP, Williams R (1980) Renin-angiotensin-aldosterone system in cirrhosis. Gut 21(6):545\u2013554","journal-title":"Gut"},{"key":"957_CR46","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1440-1746.2004.03471.x","volume":"19","author":"Witzke","year":"2004","unstructured":"Witzke O, Baumann M, Patschan D et al. (2004) Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol 19(12):1369\u20131373","journal-title":"J Gastroenterol Hepatol"},{"key":"957_CR47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","volume":"40","author":"Wong","year":"2004","unstructured":"Wong F, Pantea L, Sniderman K (2004) Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 40(1):55\u201364","journal-title":"Hepatology"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-005-0957-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-005-0957-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-005-0957-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T19:45:36Z","timestamp":1626896736000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-005-0957-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["957"],"URL":"https:\/\/doi.org\/10.1007\/s00101-005-0957-4","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}